Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study-Reference-Cited by-同舟云学术

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

Published:2013-03 Issue:9868 Volume:381 Page:735-743
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Raffi Francois,Rachlis Anita,Stellbrink Hans-Jürgen,Hardy W David,Torti Carlo,Orkin Chloe,Bloch Mark,Podzamczer Daniel,Pokrovsky Vadim,Pulido Federico,Almond Steve,Margolis David,Brennan Clare,Min Sherene

Publisher

Elsevier BV

Subject

General Medicine

Reference28 articles.

1. British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008;Gazzard;HIV Med,2008

2. European AIDS Clinical Society (EACS) guidelines for the clinical management and treatment of HIV-infected adults;Clumeck;HIV Med,2008

3. Antiretroviral treatment of adult HIV infection: 2008 recommendations of the International AIDS Society–USA Panel;Hammer;JAMA,2008

4. Isentress: USA prescribing information;Merck,2011

5. Isentress: summary of product characteristics,2011

Cited by 457 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Viral Suppression in Paediatric Populations: Implications for the Transition to Dolutegravir-Based Regimens in Cameroon: The CIPHER-ADOLA Study;Biomedicines;2024-09-12

2. A Model‐Based Approach Supporting Abacavir/Dolutegravir/Lamivudine Fixed‐Dose Combination Approval in Children Living with HIV‐1;The Journal of Clinical Pharmacology;2024-09-05

3. The differential effects of integrase strand transfer inhibitors and efavirenz on neuropsychiatric conditions and brain imaging in HIV-positive men who have sex with men;Biosafety and Health;2024-08

4. The impact of analytical treatment interruptions and trial interventions on time to viral re‐suppression in people living with HIV restarting ART in cure‐related clinical studies: a systematic review and meta‐analysis;Journal of the International AIDS Society;2024-08

5. Evaluating the glycemic effects of Dolutegravir and its predictors among HIV patients in Uganda: A prospective cohort study;2024-07-15